stromal

Chun Zhuang1, Xiaoqi Li1, Linxi Yang1

  • 1Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in oncology
|September 7, 2023
PubMed
概括

转激素受体 (TFRC) 在高危胃肠道 stromal 瘤 (GIST) 患者上调. 高TFRC表达预测无复发的生存率,建议它作为一个潜在的预后生物标志物和治疗目标在GIST.